» Articles » PMID: 2063479

Further Subclassification of ATP Receptors Based on Agonist Studies

Overview
Specialty Pharmacology
Date 1991 Apr 1
PMID 2063479
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies using agonist analogues of ATP and other nucleotides have generated some surprising observations which may have ramifications for the classification of P2 receptors, particularly for those responses currently attributed to P2Y receptor activation. 2-MethylthioATP (2-MeSATP), the conventional P2Y receptor agonist, does not interact with ATP in the expected fashion in various models of endothelial function, suggesting that it acts by a different mechanism. Furthermore, in certain cell types where responses to ATP are mediated by phospholipase C activation, 2-MeSATP has little or no activity. Interestingly, the pyrimidine uridine triphosphate (UTP) invariably shows similar potency to ATP in systems where 2-MeSATP is inactive. In this article Steve O'Connor and colleagues discuss these data and their significance, and propose that separate receptors may be responsible: one sensitive to 2-MeSATP and the other, a 'nucleotide' receptor, sensitive to UTP.

Citing Articles

Purinergic regulation of pulmonary vascular tone.

Alveal M, Mendez A, Garcia A, Henriquez M Purinergic Signal. 2024; 20(6):595-606.

PMID: 38713328 PMC: 11554604. DOI: 10.1007/s11302-024-10010-5.


Physiologic roles of P2 receptors in leukocytes.

Alberto A, da Silva Ferreira N, Bonavita A, Nihei O, Farias F, Bisaggio R J Leukoc Biol. 2022; 112(5):983-1012.

PMID: 35837975 PMC: 9796137. DOI: 10.1002/JLB.2RU0421-226RR.


Exploring the Therapeutic Potential of Targeting Purinergic and Orexinergic Receptors in Alcoholic Neuropathy.

Madaan P, Behl T, Sehgal A, Singh S, Sharma N, Yadav S Neurotox Res. 2022; 40(2):646-669.

PMID: 35080764 DOI: 10.1007/s12640-022-00477-8.


That was then, this is now: the development of our knowledge and understanding of P2 receptor subtypes.

Kennedy C Purinergic Signal. 2021; 17(1):9-23.

PMID: 33527235 PMC: 7954963. DOI: 10.1007/s11302-021-09763-0.


Characterisation of P2Y receptors in human vascular endothelial cells using AR-C118925XX, a competitive and selective P2Y antagonist.

Muoboghare M, Drummond R, Kennedy C Br J Pharmacol. 2019; 176(16):2894-2904.

PMID: 31116875 PMC: 6637037. DOI: 10.1111/bph.14715.